The International Stroke Trial database

Trials

Volumn 12, Issue , 2011, Pages

  Sandercock, Peter A G ^a   Niewada, Maciej ^b,c   Członkowska, Anna ^b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; INDIVIDUALIZATION; INTERNATIONAL STROKE TRIAL DATABASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; ACCESS TO INFORMATION; ASIA; AUSTRALIA; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; COOPERATION; DAILY LIFE ACTIVITY; DISABILITY; DRUG ADMINISTRATION; DRUG COMBINATION; EUROPE; INTERNATIONAL COOPERATION; METHODOLOGY; MORTALITY; MULTICENTER STUDY; NEW ZEALAND; PROSPECTIVE STUDY; RECURRENT DISEASE; SOUTH AFRICA; SOUTH AMERICA; STROKE; TIME; TREATMENT OUTCOME; UNITED STATES;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ACCESS TO INFORMATION; ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; ANTICOAGULANTS; ASIA; ASPIRIN; AUSTRALIA; CANADA; COOPERATIVE BEHAVIOR; DATABASES AS TOPIC; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INTERNATIONAL COOPERATION; MALE; NEW ZEALAND; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RECURRENCE; RESEARCH DESIGN; SOUTH AFRICA; SOUTH AMERICA; STROKE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79954589818     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-101     Document Type: Article

References (8)

1. Sandercock P, Collins R, Counsell C, Farrell B, Peto R, Slattery J, Warlow C, . International Stroke Trial Collaborative Group The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997, 349:1569-1581. 10.1016/S0140-6736(97)04011-7, 9174558, International Stroke Trial Collaborative Group.
2. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. Trials 2010, 11:9. 10.1186/1745-6215-11-9, 2825513, 20113465., http://www.trialsjournal.com/content/11/1/9
3. Weir NU, Sandercock P, Lewis SC, Signorini D, Warlow CP, . on behalf of the IST Collaborative Group Variations between countries in outcome after stroke in the International Stroke Trial (IST). Stroke 2001, 32:1370-1377. on behalf of the IST Collaborative Group.
4. Irwin P, Hoffman A, Lowe D, Pearson M, Rudd AG. Improving clinical practice in stroke through audit: results of three rounds of National Stroke Audit. J Eval Clin Pract 2005, 11:306-314. 10.1111/j.1365-2753.2005.00529.x, 16011643.
5. Kengne AP, Anderson CS. The neglected burden of stroke in Sub-Saharan Africa. International Journal of Stroke 2006, 1:180-190. 10.1111/j.1747-4949.2006.00064.x, 18706015.
6. Sanossian N, Ovbiagele B. Prevention and management of stroke in very elderly patients. Lancet Neurol 2009, 8:1031-1041. 10.1016/S1474-4422(09)70259-5, 19800847.
7. Deeks JJ, Dinnes J, D'Amico RA, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technology Assessment 2003, 7:1-173.
8. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ. Indirect comparisons of competing interventions. Health Technology Assessment 2005, 9:1-148.